{
    "title": "AstraZeneca suffers setback as drug fails in eye cancer",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-3170444/AstraZeneca-suffers-setback-drug-fails-eye-cancer.html",
    "date": "2015-07-22",
    "keywords": [
        "cancer",
        "drug",
        "selumetinib",
        "astrazeneca",
        "oncology",
        "eye",
        "gmt",
        "july",
        "ben",
        "trial",
        "drugmaker",
        "melanoma",
        "lung",
        "analyst",
        "phase",
        "sumit",
        "percent",
        "development",
        "louise",
        "email",
        "hirschlerlondon",
        "pipeline",
        "blow",
        "wednesday",
        "goal",
        "latestage",
        "eyethe",
        "result",
        "treatment",
        "nonsmall",
        "cell",
        "cancerselumetinib",
        "class",
        "mek",
        "product",
        "mekinist",
        "compound",
        "cobimetinib",
        "roche",
        "consensus",
        "use",
        "chemotherapy",
        "point",
        "thomson",
        "alistair",
        "campbell",
        "failure",
        "surprise",
        "ii",
        "datahowever",
        "lynparza",
        "medi4736",
        "turnaround",
        "tradinguveal",
        "disease",
        "malignancy",
        "melanomasthe",
        "opportunity",
        "neurofibromatosis",
        "condition",
        "tumours",
        "grow",
        "nervesselumetinib",
        "programme",
        "rationale",
        "monotherapy",
        "head",
        "impact",
        "data",
        "courseoncology",
        "priority",
        "area",
        "group",
        "hirschler",
        "editing",
        "weir"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}